Streptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine.

about

Streptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine.

Item

http://www.wikidata.org/entity/Q35569198

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Streptococcus pneumoniae menin ...... neumococcal conjugate vaccine.

@ast

Streptococcus pneumoniae menin ...... neumococcal conjugate vaccine.

@en

type

Item

label

Streptococcus pneumoniae menin ...... neumococcal conjugate vaccine.

@ast

Streptococcus pneumoniae menin ...... neumococcal conjugate vaccine.

@en

prefLabel

Streptococcus pneumoniae menin ...... neumococcal conjugate vaccine.

@ast

Streptococcus pneumoniae menin ...... neumococcal conjugate vaccine.

@en

P1476

Streptococcus pneumoniae menin ...... pneumococcal conjugate vaccine

@en

P2093

Gregory J Tyrrell

http://www.w3.org/2001/XMLSchema#string

Sipi Garg

http://www.w3.org/2001/XMLSchema#string

Streptococcus pneumoniae Alberta Team (SPAT) group

http://www.w3.org/2001/XMLSchema#string

Thomas J Marrie

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Corticosteroids for acute bacterial meningitis

Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection.

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Clinical features and prognostic factors in adults with bacterial meningitis.

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known.

Dexamethasone in adults with bacterial meningitis.

P304

137-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/179170

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James D Kellner

Jennie Johnstone

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23205025

http://www.w3.org/2001/XMLSchema#string

P921

meningitis

P932

3222760

http://www.w3.org/2001/XMLSchema#string